Related Experiment Video
Updated: Jul 21, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Decoding Oncofusions: Unveiling Mechanisms, Clinical Impact, and Prospects for Personalized Cancer Therapies
Kari Salokas1, Giovanna Dashi1, Markku Varjosalo1
1Institute of Biotechnology, HiLIFE, University of Helsinki, 00790 Helsinki, Finland.
Abstract:
Cancer-associated gene fusions, also known as oncofusions, have emerged as influential drivers of oncogenesis across a diverse range of cancer types. These genetic events occur via chromosomal translocations, deletions, and inversions, leading to the fusion of previously separate genes. Due to the drastic nature of these mutations, they often result in profound alterations of cellular behavior. The identification of oncofusions has revolutionized cancer research, with advancements in sequencing technologies facilitating the discovery of novel fusion events at an accelerated pace. Oncofusions exert their effects through the manipulation of critical cellular signaling pathways that regulate processes such as proliferation, differentiation, and survival. Extensive investigations have been conducted to understand the roles of oncofusions in solid tumors, leukemias, and lymphomas. Large-scale initiatives, including the Cancer Genome Atlas, have played a pivotal role in unraveling the landscape of oncofusions by characterizing a vast number of cancer samples across different tumor types. While validating the functional relevance of oncofusions remains a challenge, even non-driver mutations can hold significance in cancer treatment. Oncofusions have demonstrated potential value in the context of immunotherapy through the production of neoantigens. Their clinical importance has been observed in both treatment and diagnostic settings, with specific fusion events serving as therapeutic targets or diagnostic markers. However, despite the progress made, there is still considerable untapped potential within the field of oncofusions. Further research and validation efforts are necessary to understand their effects on a functional basis and to exploit the new targeted treatment avenues offered by oncofusions. Through further functional and clinical studies, oncofusions will enable the advancement of precision medicine and the drive towards more effective and specific treatments for cancer patients.
Insights
Cancer-associated gene fusions, or oncofusions, drive cancer by altering cell behavior. Further research into these genetic events promises new targeted therapies and advances in precision medicine.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Cancer-associated gene fusions (oncofusions) are key drivers of oncogenesis across various cancer types.
- These genetic events arise from chromosomal abnormalities, leading to altered gene products and profound changes in cellular behavior.
- Advancements in sequencing technologies accelerate the discovery of novel oncofusions.
Purpose of the Study:
- To review the role of oncofusions in cancer development and their impact on cellular signaling pathways.
- To highlight the significance of large-scale initiatives like The Cancer Genome Atlas in characterizing oncofusions.
- To discuss the therapeutic and diagnostic potential of oncofusions, including their role in immunotherapy and precision medicine.
Main Methods:
- Review of existing literature and large-scale cancer genomics data (e.g., The Cancer Genome Atlas).
- Analysis of oncofusion mechanisms involving chromosomal translocations, deletions, and inversions.
- Examination of oncofusions' effects on cellular signaling pathways regulating proliferation, differentiation, and survival.
Main Results:
- Oncofusions significantly alter cellular behavior by manipulating critical signaling pathways.
- Large-scale genomic studies have mapped the landscape of oncofusions across diverse cancer types.
- Oncofusions serve as potential neoantigens for immunotherapy and as diagnostic/therapeutic targets.
Conclusions:
- Oncofusions are crucial in cancer pathogenesis and represent valuable targets for novel cancer therapies.
- Despite challenges in functional validation, oncofusions hold significant potential for advancing precision medicine.
- Further research is essential to fully exploit oncofusions for developing more effective and specific cancer treatments.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers
Tumor Immunotherapy

